Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism

White, Richard; Brunson, Ann; Romano, Patrick S.; Li, Zhongmin; Wun, Theodore

doi:10.1161/circulationaha.115.020338

Cited by 75 publications

(41 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…14 In our analysis, the differences in recurrent PE were independent of the use of IVC filters, the benefits of which remain controversial, with wide variation in reported use. [15][16][17] We observed an increased risk of stroke within 30 days of thrombolysis compared with surgical embolectomy. The reported frequency of intracranial hemorrhage is 1.5% to 2.0% after thrombolysis for PE.…”

Section: Discussionmentioning

confidence: 80%

Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013

Lee

Itagaki

Chiang

et al. 2018

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 80%

Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013

Lee

Itagaki

Chiang

et al. 2018

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

“…These findings are consistent with a larger observational study including 80 697 patients with acute VTE but no contraindication for anticoagulation. The insertion of an IVC filter was not associated with a significant reduction in the 30‐day risk of mortality (HR, 1.12; 95% CI, 0.92–1.28) . However, IVC filter insertion was associated with a 50% increased risk of a new diagnosis of DVT in this patient population.…”

Section: Indications For Ivc Filtersmentioning

confidence: 73%

Inferior vena cava filters

Duffett

Carrier

2017

Journal of Thrombosis and Haemostasis

View full text Add to dashboard Cite

To cite this article: Duffett L, Carrier M. Inferior vena cava filters. J Thromb Haemost 2017; 15: 3-12.Summary. Use of inferior vena cava (IVC) filters has increased dramatically in recent decades, despite a lack of evidence that their use has impacted venous thromboembolism (VTE)-related mortality. This increased use appears to be primarily driven by the insertion of retrievable filters for prophylactic indications. A growing body of evidence, however, suggests that IVC filters are frequently associated with clinically important adverse events, prompting a closer look at their role. We sought to narratively review the current evidence on the efficacy and safety of IVC filter placements. Inferior vena cava filters remain the only treatment option for patients with an acute (within 2-4 weeks) proximal deep vein thrombosis (DVT) or pulmonary embolism and an absolute contraindication to anticoagulation. In such patients, anticoagulation should be resumed and IVC filters removed as soon as the contraindication has passed. For all other indications, there is insufficient evidence to support the use of IVC filters and high-quality trials are required. In patients where an IVC filter remains, regular follow-up to reassess removal and screen for filter-related complications should occur.

show abstract

“…They showed significant reduction in short-term risk of death only with standalone IVCF use for classic indications. 19…”

Section: White Et Al In 2016 Compared Outcomes Of Adjunctivementioning

confidence: 99%

Inferior Vena Cava Filters—Current Role and Controversies

Kapoor

Raissi

2019

J Clin Interv Radiol ISVIR

View full text Add to dashboard Cite

Inferior vena cava filters (IVCFs) remain an indispensable part of an interventionalist's toolbox. Increased recognition of filter-related complications, largely from off-label use and casual approach to filter retrieval, has led to tremendous uncertainty surrounding their use. More stringent regulations on their use and development of newer and safer anticoagulants are gradually changing their role in the management of venous thromboembolism. Herein, the authors review the current role of IVCFs, indications for their use and retrieval, as well as filter-related complications.

show abstract

Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism

Abstract: Background-Evidence

Cited by 75 publications

References 32 publications

Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013

Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013

Inferior vena cava filters

Inferior Vena Cava Filters—Current Role and Controversies

Contact Info

Product

Resources

About